A Single-dose Study to Investigate the Effects of 3 Different Doses of Inhaled AZD2115 in COPD Patients
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This study in COPD patients will investigate the bronchodilatory effect of AZD2115. AZD2115
will be tested versus placebo and active comparators. The safety and tolerability of AZD2115
including investigations of clinically relevant systemically mediated effects will also be
investigated.